Skip to main content
. 2022 Aug 11;9:989627. doi: 10.3389/fmolb.2022.989627

TABLE 6.

Details of top 10 clusters for researches on oxidative stress in intervertebral disc degeneration from 2007 to 2021.

Cluster no. Size (n) Silhouette Mean (Year) LSI LLR MI
0 65 0.545 2018 intervertebral disc degeneration; glucagon like peptide 1; transcription factor; competitive endogenous RNA; adaptation | oxidative stress; nucleus pulposus cells; mitochondrial dysfunction; activation; honokiol mitochondria; intervertebral disc degeneration; differentiation; hypoxia; promote tp53-induced glycolysis and apoptosis regulator; atf4; coculture; AMPK/pgc-1 alpha pathway; cyclosporine a
1 53 0.606 2016 intervertebral disc degeneration; low back pain; nucleus pulposus; targeted therapy; signaling pathway | intervertebral disc; oxidative stress; cell apoptosis; NF-kappa b activation; anti-senescence therapy NF-kappa b; degeneration; annulus fibrosus cell; intervertebral disk; IDD Glutathion peroxidase-1; cardiomyocyte hypertrophy; misfolded protein; involvement; cordycepin
2 49 0.626 2014 nucleus pulposus; intervertebral disc; matrix metalloproteinases; replicative senescence; oxidative stress | intervertebral disc degeneration; animal model; magnetic resonance imaging; rhesus monkey; mitochondrial dysfunction nucleus pulposus; 17 beta estradiol protect; magnetic resonance imaging; DNA damage; animal model phosphorylation; t1 rho; elderly subject; hyperosmotic stress; high glucose
3 33 0.676 2015 intervertebral disc degeneration; nucleus pulposus; intervertebral disc; primary cell culture; gene expression | oxidative stress; nucleus pulposus cells; autophagic flux; primary cell culture; intervertebral disc diabetes mellitus; reactive oxygen species; mitoq; bax; Kinsenoside mitoq; bax; kinsenoside; anti-oxidant; mangiferin
4 33 0.862 2013 intervertebral disc degeneration; noncoding RNA; aerobic metabolism; tissue; degradation | oxidative stress; intervertebral disc; HEME oxygenase-1; noncoding RNA; aerobic metabolism Osteoarthriti; nlrp3 inflammasome; degradation; gene; hbp1 hbp1; CDDO-EA; oligomeric matrix protein; aerobic metabolism; oxidative phosphorylation
5 31 0.831 2014 intervertebral disc; mitochondrial redox homeostasis; advanced glycation end products; synovial joints; pathomechanisms | intervertebral disc degeneration; advanced glycation end-products; pathomechanisms; carboxymethyl-lysine; metalloproteinases MMPS; proteomics; aging; controls; advanced glycation end products controls; advanced glycation end products; pentosidine; sirtuin 3; hemopexin
6 25 0.759 2014 low back pain; metalloproteinase; gene expression; induced inflammation; model | oxidative stress; TNF-alpha; prevalence; inflammatory cytokine; inhibitor metalloproteinase; senescence markers; induced inflammation; human retina; antioxidant system senescence markers; induced inflammation; human retina; antioxidant system; inflammatory cytokine
7 23 0.928 2012 oxidative stress; intervertebral disc; enzyme encapsulation; polymer capsules; inflammatory markers | intervertebral disc degeneration; nutrient deficiency; inflammatory markers; intervertebral disc; epigallocatechin gallate ultrastructure; hydrogen peroxide; doxorubicin; macrophage; oxidative stress markers doxorubicin; macrophage; oxidative stress markers; iron; age-related macular degeneration
8 18 0.728 2014 intervertebral disc degeneration; nucleus pulposus cells; small molecule; intervertebral disc; death | oxidative stress; mitochondrial function; nucleus pulposus-derived mesenchymal stem cells; PPAR gamma coactivator-1; silent information regulator inhibition; complement system; naringin; b; premature senescence complement system; naringin; b; premature senescence; small molecule activator
9 17 0.928 2012 intervertebral disc degeneration; oxidative stress; reactive oxygen species; mitochondral damage; high glucose | nucleus pulposus; extrogen receptor beta; clinical studies; biochemical mechanisms; transcription factor intervertebral disc degeneration; high glucose concentration; migration inhibitory factor; vo-ohpic; smg1 high glucose concentration; migration inhibitory factor; vo-ohpic; smg1; Wnt/beta-catenin signaling pathway